The new Vitassay SARS-CoV-2 + Flu A + B + RSV + Adeno Resp. is a rapid, immunochromatographic assay for the simultaneous qualitative detection of nucleoprotein antigen of SARS-CoV-2, Influenza type A, Influenza type B, RSV and Adenovirus from nasopharyngeal swabs samples from patients suspected of COVID-19 infection and/or Influenza A and/or Influenza B and/or Respiratory Syncytial Virus (RSV) and/or Adenovirus infection.
Clinically, patients with SARS-Cov-2 infection tend to suffer from mile symptoms such as fever, dry cough, anosmia, fatigue, dyspnea, headache, diarrhea, and sore throat followed by vascular and systemic complications such as leukocyte infiltration of the lungs, pneumonia, severe pneumonia, severe acute respiratory diseases syndrome (ARDS), sepsis and septic shock. Recent studies in COVID-19 patients commonly manifest olfactory and gustatory dysfunction even in the absence of rhinorrhea or nasal obstruction.
The clinical presentation of respiratory infections caused by different viral pathogens can be very similar, making etiological diagnosis difficult.
Influenza virus, respiratory syncytial virus (RSV) and adenovirus are of primary importance since infections produced by them range from mild respiratory illness to fatal pneumonia, and cause considerable morbidity and excess deaths in children, elderly people, and in immunocompromised individuals throughout the world.
More information about this test, by clicking here.